Bruker Corporation (BRKR)
After hours:
| Previous close | 80.59 |
| Open | 80.09 |
| Bid | 80.91 x 100 |
| Ask | 81.01 x 300 |
| Day's range | 80.09 - 81.96 |
| 52-week range | 53.79 - 94.86 |
| Volume | |
| Avg. volume | 831,755 |
| Market cap | 11.768B |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | 27.92 |
| EPS (TTM) | 2.90 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 0.20 (0.25%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | 88.40 |
FX EmpireBig Money Instrumental in Bruker Stock Rise
Bruker Corporation (BRKR) shares are up 10% year-to-date. Big Money investors have boosted the scientific instrument maker’s stock along the way.
Business WireBruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
BARCELONA, Spain, April 26, 2024--At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying microbiology and infectious disease diagnostics and workflows in the clinical laboratory is a key goal for Bruker in support of earlier and improved patient treatment decisions.
Business WireBruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
BILLERICA, Mass., April 25, 2024--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
